Georgia Tech Research Corporation

Grantee Website Atlanta, Georgia, United States
Purpose
to demonstrate the feasibility and efficacy of inhalation powder lung delivery of synthetic mRNA encoding broadly neutralizing antibodies against influenza infections in a rodent model
Division
Global Health
Date
JUNE 2018
Region Served
GLOBAL
Committed Amount
$447,451
Grant Topic
Support Innovative Technology Solutions
Duration (Months)
15
Grantee Location
Atlanta, Georgia, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.